Item Details
NeuroXess Raises US$96.6 Million to Advance Brain-Computer Interface Technology
Chinese medical-technology company NeuroXess completed a RMB 700 million (approximately US$96.6 million) Series B financing round on 28 October, led by institutional investors including SDIC Juli and Shenzhen Capital Group. The funding will support clinical trials, regulatory registration, manufacturing expansion and next-generation brain-computer interface development. The deal creates opportunities for clinical research organisations, medical-device manufacturers, regulatory consultants, hospital partners and healthcare technology suppliers.
Get in Touch
We’ll get back to you shortly.